An Efficacy and Safety Study of Long Acting Injectable Risperidone and Oral Risperidone in Participants With Schizophrenia or Schizoaffective Disorder
Clinical trial NCT00992407 · COMPLETED
Trial details
- NCT number
- NCT00992407
- Sponsor
- Janssen Korea, Ltd., Korea
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2010-12-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.